Boston Trust Walden’s Americold COLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-784,227
Closed -$23.8M 377
2023
Q3
$23.8M Buy
784,227
+48,260
+7% +$1.56M 0.2% 152
2023
Q2
$23.8M Sell
735,967
-217,825
-23% -$6.49M 0.2% 157
2023
Q1
$27.1M Sell
953,792
-266,327
-22% -$7.94M 0.23% 147
2022
Q4
$34.5M Sell
1,220,119
-1,346
-0.1% -$36.2K 0.3% 121
2022
Q3
$30M Buy
1,221,465
+38,520
+3% +$1.16M 0.3% 120
2022
Q2
$35.5M Buy
1,182,945
+1,168,320
+7,989% +$32.5M 0.34% 109
2022
Q1
$408K Buy
14,625
+125
+0.9% +$3.51K ﹤0.01% 331
2021
Q4
$475K Buy
+14,500
New +$448K ﹤0.01% 331

Other funds holding COLD

Boston Trust Walden's COLD Position: Q4 2023 in Review

Boston Trust Walden sold out of Americold (COLD) in Q4 2023, closing a stake of 784,227 shares — an estimated $23.8M sold.

Boston Trust Walden first reported a position in COLD in Q4 2021 and held it in 8 quarters. The position peaked at $35.5M in Q2 2022. 342 funds tracked by Wall St. Rank hold COLD as of Q4 2023.

  • Boston Trust Walden reported no remaining Americold position as of Q4 2023 after selling out during the quarter.
  • Boston Trust Walden sold 784,227 Americold shares in Q4 2023, an estimated $23.8M.
  • Boston Trust Walden first reported a position in Americold in Q4 2021 and held it in 8 quarters.
  • Boston Trust Walden's Americold position peaked at $35.5M in Q2 2022.
  • 342 funds tracked by Wall St. Rank held Americold as of Q4 2023.

Based on Boston Trust Walden's 13F filing for Q4 2023, filed 24 Jan 2024.